What Advair? GSK Plays Up Budding Oncology Pipeline In Q4 Call
Executive Summary
GSK said its oncology pipeline has doubled in size since July to include 16 assets in the clinic and highlighted the newly in-licensed bifunctional immunotherapy M7824.